Skip to main content

Hypersplenismus und Splenektomie bei inneren Krankheiten

  • Chapter
Therapie innerer Krankheiten
  • 9 Accesses

Zusammenfassung

Als Hypersplenismus oder Hyperspleniesyndrom bezeichnet man folgenden Symptomenkomplex:

  • periphere Zytopenie (Verminderung der Zellen des peripheren Blutes, wobei die einzelnen Zellreihen unterschiedlich stark betroffen sein können);

  • zellreiches (hyperregeneratorisches) Knochenmark;

  • Splenomegalie;

  • Besserung der Zytopenie nach Splenektomie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aaberge IS, Heier HE, Giercksky E-E, Groeng E-C (1984) IgM and IgG response to pneumococcal Polysacharide vaccine in normal individuals splenectomized due to trauma. Acta Pathol Microbiol Scand C: 92:11

    CAS  Google Scholar 

  2. Brigden ML (1992) Overwhelming postsplenectomy infection still a problem. West J Med 157:440–443

    PubMed  CAS  Google Scholar 

  3. Crosby WH (1972) Splenectomy in hematological disorders. N Engl J Med 2861–1252

    Google Scholar 

  4. Diehl V, Schaadt M, Kalden JR, Hagedorn CH, Schmidt N, Deinhardt J (1978) Der Einfluß der Splenektomie auf den Immunstatus des Hodgkin-Patienten. Klin Wochenschr 56: 809

    Article  PubMed  CAS  Google Scholar 

  5. Ebaugh FG, McIntyre OR (1979) Palpable Spleens: ten-year follow-up. Ann Intern Med 90:130

    Article  PubMed  Google Scholar 

  6. Editorial (1976) Tropical splenomegaly. Lancet 1:1058

    Google Scholar 

  7. Garrison RN, McCoy M, Winkler C, Yam L, Frey DE (1984) Splenectomy in hematologic malignancy. Am Surgeon 50: 428

    PubMed  CAS  Google Scholar 

  8. Hess CE, Ayers CR, Sanduusky WR et al. (1976) Mechanisms of dilutional anemia in massive splenomegaly. Blood 47:629

    PubMed  CAS  Google Scholar 

  9. Hosea SW, Brown EJ, Hamburger Mi (1981) Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304:245–250

    Article  PubMed  CAS  Google Scholar 

  10. Jaiyesimi IA, Kantarjian HM, Estey EH (1993): Advances in therapy for hairy cell leukemia. A review. Cancer 72:5–16

    Article  PubMed  CAS  Google Scholar 

  11. Livingson CD, Levine BA, Sirinek KR (1983) Site of splenic autotransplantation affects protection from sepsis. Am J Surg 146:734

    Article  Google Scholar 

  12. Marble KR, Deckers OJ, Kern KA (1993) Changing role of splenectomy for hematologic disease. J Surg Oncol 52: 169–171

    Article  PubMed  CAS  Google Scholar 

  13. Moore GE, Stevens RE, Moore EE, Aragon GE (1983) Failure of splenic implants of protect against fatal postsplenectomy infection. Am J Surg 146:413

    Article  PubMed  CAS  Google Scholar 

  14. Musser G, Lazar G, Hocking W, Busuttil RW (1984) Splenectomy for hematologic disease. The UCLA experience with 306 patients. Ann Surg 200:40

    Article  PubMed  CAS  Google Scholar 

  15. Nomikos IN (1984) Is sepsis the only possible harmful consequence of splenectomy? N Engl J Med 310:198

    Article  Google Scholar 

  16. Di Padova F, Dürig M, Harder F et al. (1985) Impaired antipneumococcal antibody production in patients without spleens. Br Med J 290:14

    Article  Google Scholar 

  17. Parker AC, Mac Pherson ACS, Richmond J (1977) Value of radiochromium investigation in autimmune hemolytic anema. Br Med J1:208

    Article  CAS  Google Scholar 

  18. Pinca A, Di Palma A, Soriani S, Sprocati M, Manella P, Georgacopulo P, Bagni B, Vullo C (1992) Effectiveness of partial splenic embolizations as treatment for hypersplenism in thalassamia major: a 7-year follow up. Eur J Haematol 49: 49–52

    Article  PubMed  CAS  Google Scholar 

  19. Pfreundschuh M, Löffler M, Rühl U et al. (1988) Therapie der Hodgkin-Lymphome — Ergebnisse der Deutschen Hodgkin-Studiengruppe, Onkologie 11:48–52

    Article  PubMed  CAS  Google Scholar 

  20. Platt R (1983) Infection after splenectomy. JAMA 248:2316

    Article  Google Scholar 

  21. Randi ML, Fabris F, Dona S, Girolami A (1987) Evaluation of platelet function in postsplenectomy thrombocytosis. Folia Haematol 114:252–256

    CAS  Google Scholar 

  22. Rosenberg SA (1985) Laparatomy and splenectomy in Hodgkin’s disease: A reappraisal after twenty years. Scand J Haematol 34:289

    Article  PubMed  CAS  Google Scholar 

  23. Rosse WF (1987) The spleen as a filter. N Engl J Med 317:704

    Article  PubMed  CAS  Google Scholar 

  24. Sass W, Bergholz M, Kehl A, Seifert J, Hamelmann H (1983) Overwhelming infection after splenectomy in spite of some spleen remaining as splenosis. Klin Wochenschr 61:1075

    Article  PubMed  CAS  Google Scholar 

  25. Scholz KH, Herrmann C, Tebbe U, Chemnitius JM, Helmchen U, Kreuzer H (1993) Myocardial infarction in young patients with Hodgkin’s disease — potential pathogenic role of radiotherapy, chemotherapy and splenectomy. Clin Invest 71:57–64

    Article  CAS  Google Scholar 

  26. Schwartz PE, Sterioff S, Mucha P, Melton LJ, Offord KP (1982) Postsplenectomy sepsis and mortality in adults. JAMA 248:2279

    Article  PubMed  CAS  Google Scholar 

  27. Sekikawa T, Shatney CH (1983) Septic sequelae after splenectomy for trauma in adults. Am J Surg 145:667

    Article  PubMed  CAS  Google Scholar 

  28. Shimm DS, Linggood RM, Weitzman SA (1983) Overwhelming postsplenectomy infection in Hodgkin’s disease: Pathogenesis and prevention. Clin Radiol 34:95

    Article  PubMed  CAS  Google Scholar 

  29. Silverstein MN; Remine WH (1979) Splenectomy in myeloid metaplasia. Blood 53:515

    PubMed  CAS  Google Scholar 

  30. Simberkoff MS, Corss AP, Ai-Ibrahim M et al. (1986) Efficacy of pneumococcal vaccine in high-risk-patients: results of a Veterans Administrations coopertaive study. N Engl J Med 315:1318

    Article  PubMed  CAS  Google Scholar 

  31. Stutte HJ (1984) Milz. In: Remmele W (Hrsg) Pathologie, Bd 1. Springer, Berlin Heidelberg New York Tokyo, S 489

    Chapter  Google Scholar 

  32. Turner J, Turner AR, Evan-Wong A (1992) Successful splenectomy for lymphoproliferative disease on octogenarians. Br. J Surg 79:775

    Article  PubMed  CAS  Google Scholar 

  33. Velden JW van der, Putten WL van, Guinée VF, Pfeiffer R, Leeuwen FE van, Linden EA van der, Vardomskaye I, Lane W, Durand M, Lagarde C (1988) Subsequent development of acute non-lymphocytic leukemia in patients treatment for Hodgkin’s disease. Int J Cancer 42:252–255

    Article  PubMed  Google Scholar 

  34. Wobbes T, Sluis RF van der, Lubbers E-JC (1984) Removal of the massive spleen: a surgical risk? Am J Surg 147:800

    Article  PubMed  CAS  Google Scholar 

  35. Zarrabi MH, Rosner F (1986) Rarity of failure or penicillin prophylaxis to prevent postsplenectomy sepsis. Arch Intern Med 146:1207

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pfreundschuh, M., Diehl, V. (1995). Hypersplenismus und Splenektomie bei inneren Krankheiten. In: Paumgartner, G., Riecker, G. (eds) Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10479-8_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10479-8_44

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10480-4

  • Online ISBN: 978-3-662-10479-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics